Literature DB >> 17597603

Role for NK(1) and NK(2) receptors in the motor activity in mouse colon.

Flavia Mulè1, Antonella Amato, Rosa Serio.   

Abstract

The present study examined the effects induced by endogenous and exogenous activation of NK(1) and NK(2) receptors on the mechanical activity of mouse proximal colon. Experiments were performed in vitro recording the changes in intraluminal pressure from isolated colonic segments. Electrical field stimulation in the presence of atropine and guanethidine produced a small relaxation, followed by nonadrenergic noncholinergic (NANC) contraction. SR140333, NK(1) receptor antagonist, or SR48968, NK(2) receptor antagonist, significantly reduced the contraction, although SR48968 appeared more efficacious. The co-administration of SR140333 and SR48968 virtually abolished the NANC contraction. [Sar(9), Met(O(2))(11)]-substance P, selective NK(1) receptor agonist, induced a concentration-dependent biphasic effect, contraction followed by reduction of the mechanical spontaneous activity. Both effects were antagonized by SR140333, but not by SR48968. [beta-Ala(8)]-neurokinin A (4-10), selective NK(2) receptor agonist, evoked concentration-dependent contraction, which was antagonized by SR48968, but not by SR140333. The contraction induced by [Sar(9), Met(O(2))(11)]-substance P, but not by [beta-Ala(8)]-neurokinin A (4-10), was reduced by tetrodotoxin or atropine, and increased by N(omega)-nitro-L-arginine methyl ester (L-NAME), inhibitor of nitric oxide synthase. The inhibitory effects induced by [Sar(9), Met(O(2))(11)]-substance P were abolished by tetrodotoxin or L-NAME. The results of the present study suggest that in mouse colon both NK(1) and NK(2) receptors are junctionally activated by endogenous tachykinins to cause an additive response. NK(1) receptors appear to be located on cholinergic and on nitrergic neurons as well as on smooth muscle cells, whereas NK(2) receptors seem to be present exclusively on smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597603     DOI: 10.1016/j.ejphar.2007.05.036

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.

Authors:  M Bashashati; M A Storr; S P Nikas; J T Wood; G Godlewski; J Liu; W Ho; C M Keenan; H Zhang; S O Alapafuja; B F Cravatt; B Lutz; K Mackie; G Kunos; K D Patel; A Makriyannis; J S Davison; K A Sharkey
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice.

Authors:  Kun Li; Jakub Fichna; Rudolf Schicho; Dieter Saur; Mohammad Bashashati; Ken Mackie; Yongyu Li; Andreas Zimmer; Burkhard Göke; Keith A Sharkey; Martin Storr
Journal:  Neuropharmacology       Date:  2013-04-18       Impact factor: 5.250

Review 3.  The Neuromodulation of the Intestinal Immune System and Its Relevance in Inflammatory Bowel Disease.

Authors:  Martina Di Giovangiulio; Simon Verheijden; Goele Bosmans; Nathalie Stakenborg; Guy E Boeckxstaens; Gianluca Matteoli
Journal:  Front Immunol       Date:  2015-11-20       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.